| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00537667 Details | 2009-11-26 Interventional | 2 | 22 | Interleukin 1 R… Arthritis Arthritis, Rheu… Rheumatoid Arth… | The safety profile of combination therapy became unacceptable. - | |||
| NCT00647972 Details | 2009-11-23 Interventional | 1 | 32 | Olanzapine Healthy | during Period 1 due to numerous orthostatic AEs that occurred. Subsequently, RLD was reduced to
5 mg due to safety concerns. - | |||
| NCT00391950 Details | 2009-11-23 Interventional | 3 | - | Zoledronic Acid Prostatic Neopl… Prostate Cancer | - - | |||
| NCT00372710 Details | 2009-11-23 Interventional | 3 | - | Zoledronic Acid Breast Neoplasm… Neoplasm Metast… Breast Cancer W… | - - | |||
| NCT00494026 Details | 2009-11-20 Interventional | 2 | 4 | Carboplatin Pemetrexed Lung Neoplasms Small Cell Lung… Small Cell Lung… | Study stopped early based on interim results of another trial, showing inferior activity of
pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC. - | |||
| NCT00468260 Details | 2009-11-19 Interventional | 1 | - | Epothilone B Neoplasms Advanced Malign… | pts. will be captured in core - | |||
| NCT00780728 Details | 2009-11-13 Interventional | 3 | - | Sildenafil Citr… Hypertension Hypertension, P… Pulmonary Arter… | - - | |||
| NCT00244504 Details | 2009-11-10 Interventional | 3 | 141 | Moxonidine Heart Diseases Cardiac Disease Vascular Surger… | Study was stopped after pre-definied interim analysis because of no effects - | |||
| NCT00440674 Details | 2009-10-30 Interventional | 4 | 18 | Paclitaxel Coronary Artery… Dilatation, Pat… | - - | |||
| NCT00447421 Details | 2009-10-28 Interventional | 1/2 | 9 | Pemetrexed Carcinoma, Smal… Lung Neoplasms Small Cell Lung… SCLC Small Cell Lung… | Interim results of another trial showed inferior activity of treatment The Study Phase 1 was stopped early based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in extensive small cell lung cancer. The Study did not progress to Phase 2. | |||
| NCT00074334 Details | 2009-10-21 Interventional | 1/2 | 3 | Immunotoxins Central Nervous… Nervous System … Brain and Centr… | Drug company withdrawal of support for investigational agent in this indication. - | |||
| NCT00998608 Details | 2009-10-20 Interventional | 4 | [5 Refs] | 88 | Risperidone Schizophrenia | terminated - | ||
| NCT00368264 2005-004067-30 Details | 2009-10-05 Interventional | 2/3 | 1 | Infliximab Lupus Erythemat… Lupus Nephritis Nephritis | Failure to recruit patients with membranous lupus nephritis not previously treated with
azathioprine . - | |||
| NCT00494338 Details | 2009-10-01 Interventional | 2 | 6 | Docetaxel Prostatic Neopl… Metastatic Pros… | due to celecoxib safety issues - | |||
| NCT00544180 Details | 2009-09-25 Interventional | 4 | 7 | Risedronic Acid Osteoporosis | The trial was terminated due to lack of compliance with GCP regulations. - | |||
| NCT00409344 Details | 2009-09-22 Interventional | 4 | 0 | Dexmedetomidine Aneurysm Aortic Aneurysm Aortic Aneurysm… Aortic Aneurysm… Length of Stay Respiration, Ar… Sedation | Surgical approach changed therefore subject enrollment not possible. Unable to enroll participants into the study | |||
| NCT00273507 Details | 2009-09-18 Interventional | 3 | - | Carboplatin Paclitaxel Carcinoma, Non-… Lung Neoplasms Non-small Cell … | - - | |||
| NCT00000157 Details | 2009-09-17 Interventional | 3 | - | Aspirin Cataract | - - | |||
| NCT00929630 Details | 2009-09-16 Interventional | 3 | 65 | Fibrin Tissue A… Fistula Rectal Fistula Anal Fistulas | Evident advantages of one treatment (seton) over the other (Tissucol Glue) - | |||
| NCT00782041 Details | 2009-09-15 Interventional | 2 | 11 | Fluorouracil Folic Acid Leucovorin Levoleucovorin Oxaliplatin Uterine Neoplas… | protocol violation - |